the market for crispr/cas9 2016
TRANSCRIPT
©2016 BioInformatics LLC www.gene2drug.com
REPORT OVERVIEW
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing ProductsMAY 2016
Report #16-008
New Updated Pricing Model Now starting at $3,500
Request a Live Demo or Purchase Today
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 2
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today
n TABLE OF CONTENTS
n STUDY SCOPE ..........................................................................................................................................................................3
n REPORT HIGHLIGHTS .......................................................................................................................................................4
n OVERVIEW .................................................................................................................................................................................6
n INTERACTIVE MARKET INTELLIGENCE .......................................................................................................... 8
n SELECTED DATA .................................................................................................................................................................10
n METHODOLOGY .................................................................................................................................................................. 12
n PRICING ...................................................................................................................................................................................... 13
n CURRENT 2016 REPORT TITLES ..........................................................................................................................16
n ABOUT BIOINFORMATICS LLC .............................................................................................................................. 17
Report #16-008
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 3
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today
STUDY SCOPE
n STUDY SCOPEThis Interactive Market Intelligence report will help you to compete in The Market for CRISPR/Cas9 Genome Editing Products:
n Estimate market size, share and growth by region, industry segment and product category
n Understand the drivers of brand loyalty and compare brand performance
n Measure customer satisfaction with CRISPR/Cas9 products
n Highlight the strengths and weaknesses of competitors and their customers’ likelihood-to-switch
n Compare to 2015 data to monitor trends and identify changes
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 4
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today
REPORT HIGHLIGHTS
n REPORT HIGHLIGHTSMarket Analytics
n Current and planned use of genome editing tools
n Length of time utilizing genome editing tools
n Importance of CRISPR/Cas9 in achieving experimental objectives
n Lab annual budget for CRISPR/Cas9 products and service
n Spending projections for next 12 months
n Number of CRISPR experiments per month
n Number of guide RNA’s designed per CRISPR target experiment
n Number of targets edited or controlled per experiment
n Expected growth in use of CRISPR
Brand Analytics
n●PrimarysupplierofCRISPR/Cas9products/services
n●OverallsatisfactionwithsuppliersofCRISPR/Cas9products/services
n●CurrentandfutureuseofCRISPR-relatedservices
Customer Analytics
n●Useofconsumables
n●OverallsatisfactionwithCRISPR/Cas9products/services
n●Likelihood-to-repurchaseCRISPR/Cas9products/servicesfromcurrentsupplier
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 5
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today
REPORT HIGHLIGHTS
n Report highlights (continued)
n●Likelihood-to-recommendcurrentsupplierofCRISPR/Cas9products/services
n●Likelihood-to-switchcurrentsupplierofCRISPR/Cas9products/services
n●Factorsinfluencingdecisiontoswitchsuppliers
n●Suppliertowhothecustomerwillswitch
Workflow Analytics
n●Primaryresearchobjectives
n●CRISPR/Cas9experimentaldesign
n●Modelsystemsused
n●DesigntoolsusedtogenerateguideRNAs
n●Satisfactionwithdesigntoolsused
n●FormatsusedwhengeneratingCas9proteinsandguideRNAs
n●Sourcesofvectors
n●DeliverymethodsforCAS9proteinandguideRNAformats
n●Cas9proteinorCas9variantscurrentlyusedandplantouse
n●Useoflibrary-basedapproachfordeliveringmultipleguideRNAs
n●SourcesofguideRNAlibraries
n●GuideRNAlibraryformats
n●UseofDNAforhomologousrecombination
n●TechniquesusedtoassurespecificityofCRISPR/Cas9genomeediting
n●FutureproductneedsforCRISPR/Cas9experiments
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 6
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today
OVERVIEW
n OVERVIEWSince BioInformatics LLC last published on the CRISPR/Cas9 genome-editing system,
thescientificcommunityhaswitnessedatorrentofnewpublicationswhileinstitutions,
both private and public alike, have poured over a billion dollars into R&D for the emerging
technique.Theirinvestmentwaswellfounded.In2015,CRISPR/Cas9wasseenasthekey
tounlockingtheelusivegenome,apredicationthat2016hasbeguntoseefulfilled.With
CRISPR/Cas9, researchers have found at their disposal a novel nuclease directing system
where the ease of use, rate of performance, and versatility are unparalleled by alternative
techniques.CRISPR/Cas9hasnotonlyrevitalizedgenomeengineering,ithasrevolutionized
thefield.
Since its advent, the CRISPR/Cas9 system has seen exponential increase in applications,
each of which constituted novel market trends. Some recent developments include:
n Introduction of synthetic crRNA and tracrRNA that bypass the endogenous steps needed to createsgRNA,effectivelyeliminatingtheneedforadditionalcloningandpurificationsteps.
n Cataloging of sgRNAs into libraries that can be screened for novelties, such as the up-regulation of oncogenes in cancer cells.
nModifiedCas9endonucleasesthatnickDNAtocreatesingle-strandedbreaksratherthanfull,double-strandedcleavage.Thismethodpromoteshomology-directedrepair(HDR),limitsoff-targeteffects,andincreasesthenumberofsequencesthatcanbeusedforsite-dependentgenemodifications.
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 7
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today n Overview (continued)
nIdentificationandanalysisofproteinbindingdomainstodirectdrugdevelopment.
nDirectingofchromosomalrecombinationforhigh-fidelitymappingoftraitsofinterest,which have in turn lead to the discovery of novel genes.
n Generation of ribonucleoprotein complexes from Cas9 and gDNA. These non-viral nucleasescleaveDNAimmediatelyuponinvasion,degradequicklyandskipnative,time-consuming Cas9 activation pathways.
n Combination of CRISPR/Cas9 with lambda red for recombineering. This allows for the knockout of disparate gene combinations, such as those pivotal in metabolic pathways.
The sheer volume of applications is staggering and, as with any breakthrough,
corporate giants have reoriented their priorities while emerging biotechs have sprung
up around the world, all in hopes to claim market share. In this rapidly evolving
environment, companies are faced with the challenge of leveraging their current
strengthstobreakintoafieldthatisflushwithnewcompetition.Inthesamewaythat
CRISPR/Cas9affordedscientiststheopportunitytoexpandtheirreach,sotodoes
our2016MarketforCRISPR/Cas9Reportequipsupplierswiththetoolstheyneedto
capitalize on this emergent technology.
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 8
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today
n INTERACTIVE MARKET INTELLIGENCEThe Market for CRISPR/Cas9 Genome Editing Products utilizes our ground
breaking Interactive Market Intelligence solution that is changing the way market
research is reported and used. Traditional market research reports delivered in print
or PDF depict data in standard charts and graphs. In contrast, Interactive Market
Intelligence incorporates dynamic data visualization that adds a new dimension to
marketanalytics.Fromcorporateboardroomstorepsinthefield,Interactive Market
Intelligence delivers market data through visually engaging and customizable
dashboards.Customizedviewofthedatacanbeeasilyexportedintooffline
presentations as needed.
INTERACTIVE MARKET INTELLIGENCE
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 9
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today n INTERACTIVE MARKET INTELLIGENCE (continued)
Interactive Market Intelligence is a web-based market research delivery platform
that provides data reporting superior to PDF reports, PowerPoint and other business
intelligence tools. Unlike a PowerPoint presentation which is linear and static, one of
the core features of Interactive Market Intelligence istheabilityofuserstofilter
and create literally hundreds of views of data—all easily obtainable from a small set
of core “key metrics” slides that include Market, Brand and Customer analytics in
well-definedsegmentsofthelifesciencemarket.
With your purchase of this report, we invite you to set up a meeting with our report
teamofscientificandbusinessanalysts.Wecanansweranyquestionsyoumay
have about the study results and we can share with you what we believe to be the
significanttrendsaffectingyourmarket.
INTERACTIVE MARKET INTELLIGENCE
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 10
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today
SELECTED DATA
MARKET ANALYTICS SNAPSHOT: INCIDENCE OF LABS USING CRISPR/Cas9
n SELECTED DATA
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 11
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today
SELECTED DATA
BRAND ANALYTICS: BRAND REPUTATION COMPARISON
n SELECTED DATA
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 12
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today
METHODOLOGY
n METHODOLOGYThis Interactive Market Intelligence report will be based on the responses of approximately
300 current end-users of CRISPR/Cas9 technology and several hundred users of competing
techniquesandplannedadopters.Theresultsarepresentedonlineusingourinnovative
Interactive Market Intelligence online dashboard and refreshed with biannual updates.
Request a Live Demo or Purchase Today
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 13
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today
PRICING
n PRICINGWhy Buy Our ReportsSource of Independent, Unbiased Research
Unlikereportsfromotherfirmsthatarebasedonanalyst’ssubjectivesummaryof
information from publicly available sources, our reports are based on the results of
detailedsurveysofhundreds—eventhousands—ofscientificandmedicalprofessionals
who buy your products.
Developed by a Team of Experts
Ourquestionnairesaredevelopedbyamultidisciplinaryteamofscientists,industry
veterans and market research experts with years of experience. These professionals
understandthatsurveyquestionsneedtobeaskedinawaythatensurestheanswers
will directly address the business challenges you face. Once the survey data is collected,
thissameteamcreatesauniquereportthepresentsthereaderwithathorough
understandingofthetopic,andthescientificandbusinessimplicationsoftheresults
based on sophisticated statistical analytics.
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 14
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today Carefully Selected Survey Participants
When others promote results from their online surveys, they fail to mention the
uncontrolled nature of their broadcast email invitations. To provide you with the most
valid and accurate results possible, the respondents to our surveys are members of
ouruniqueonlinepanel—TheScienceAdvisoryBoard®—which consists of thousands
verifiedlifescienceandbiomedicalprofessionalswhohaveagreedtotakepartinour
surveys, focus groups and other market research activities. These respondents are
carefullyselectedbasedontheirprofessionalqualifications,marketsegmentsand
geographic regions. We can even select them based on the products they use and
their preferred suppliers.
Complimentary Consulting Provided
Withyourpurchase,weofferonefreehourofconsultationwithourtalentedteam
ofscientificandbusinessanalystswhocreatedthereports.Duringthisconsultation,
wecanansweranyquestionsyoumayhaveaboutthesurveyresultsandwhatwe
believetobethesignificanttrendsaffectingthemarket.
PRICING
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 15
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today Custom Analysis & Research Available
If you’d like to delve deeper into the data from a study, we can always perform
custom cross-tabulations or other analysis on your behalf. We can even pose follow-
upquestionstorespondentswhoansweredinaparticularwayorconductacustom
study to extend your knowledge.
Takeadvantageoftheuniquecapabilitiesofthis Interactive Market Intelligence
analytics model from BioInformatics LLC accessible from anywhere at anytime on
your laptop or tablet.
All licenses are active for a 12-Month term.
Single User Log-In: $3,500
Up to 5 User Log-Ins: $5,500
Company-Wide License (for up to 25 User Log-Ins): $7,500
Includes access to the 2015 report to monitor trends and changes in the market.
With your purchase of this report, we also invite you to set up a meeting with our
reportteamofscientificandbusinessanalysts.Wecanansweranyquestionsyou
may have about the survey results, and we can also share what we believe to be the
significanttrendsaffectingyourmarket.
PRICING
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 16
Interactive Market Intelligence: The Market for CRISPR/Cas9 Genome Editing Products
Request a Live Demo or Purchase Today
n CURRENT 2016 REPORT TITLES:
Digital Marketing to Life Scientists: Building Digital Loyalty Now Available
The Market for Real-Time PCR Now Available
The Market for Cell-Based Assays Now Available
The Market for CRISPR/Cas9 Genome Editing Products Now Available
CLICK HERE FOR A COMPLETE LIST OF OUR REPORTS
@2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005©2016 BioInformatics LLC www.gene2drug.com 17
n ABOUT BIOINFORMATICS LLC
BioInformatics LLC, along with our SDi division, is the premier research and advisory
firmservingthelifescienceandanalyticalinstrumentindustry.Since1994,wehave
beenprovidingoff-the-shelfreports,custom-designedstudiesandmarketanalysisthat
enable companies to understand their market and competitors through the eyes of the
most important information source of all — the people who buy their products.
By leveraging our online professional network of tens of thousands of biomedical
researchers, we have supported more than 500 companies and provided insights
that lead to better business decisions. Our expertise includes assessing the size and
attractivenessofmarkets,optimizingproductconfigurationsandpricing,validating
corporateacquisitions,measuringcustomers’brandloyalty,andevaluatingbrand
strength and positioning.
FormoreinformationaboutBioInformatics’productandserviceofferings,
please visit our website at www.gene2drug.com, call 703.778.3080 x15,
or email [email protected]
CLICK HERE FOR A COMPLETE LIST OF OUR REPORTS
Request a Live Demo or Purchase Today